Triple

T17262091
Position Surface form Disambiguated ID Type / Status
Subject Biota Holdings E419031 entity
Predicate commercializationPartner P282 FINISHED
Object Glaxo Wellcome E2086 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Glaxo Wellcome | Statement: [Biota Holdings, commercializationPartner, Glaxo Wellcome]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Glaxo Wellcome
Context triple: [Biota Holdings, commercializationPartner, Glaxo Wellcome]
  • A. GlaxoSmithKline chosen
    GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
  • B. Burroughs Wellcome Company
    Burroughs Wellcome Company was a pioneering American pharmaceutical firm known for its significant contributions to drug research and development in the 20th century.
  • C. Smith, Kline & French
    Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
  • D. Merck & Co.
    Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
  • E. Pharmacia
    Pharmacia was a major pharmaceutical company known for its global drug development and manufacturing operations before ultimately becoming part of Pfizer.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: commercializationPartner
Context triple: [Biota Holdings, commercializationPartner, Glaxo Wellcome]
  • A. cooperationPartner
    Indicates that two entities are engaged in a collaborative relationship, working together toward shared goals or mutual benefit.
  • B. acquisitionPartner
    Indicates a relationship where one entity collaborates with or assists another in acquiring a third entity, asset, or resource.
  • C. businessPartner chosen
    Indicates a formal collaborative relationship between two entities that work together in a business context, typically sharing responsibilities, risks, or benefits.
  • D. projectPartners
    Indicates that two or more entities collaborate together as partners on the same project.
  • E. selectedPartner
    Indicates that one entity has been chosen or designated as the partner of another entity.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d886d9ab108190b70edd8d17aa1204 completed April 10, 2026, 5:12 a.m.
NER Named-entity recognition batch_69e42e717a348190ae6835fb08f38125 completed April 19, 2026, 1:22 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0180ce69d08190aa254f219a572a92 completed May 11, 2026, 7:10 a.m.
PD Predicate disambiguation batch_69e3832a284481908a8a3da7ac91de5a completed April 18, 2026, 1:12 p.m.
Created at: April 10, 2026, 5:39 a.m.